Company Filing History:
Years Active: 2000-2004
Title: **Robert Gail Billings: Advancements in Hematocrit Measurement**
Introduction
Robert Gail Billings is an innovative inventor based in Salt Lake City, UT, renowned for his contributions to medical technology. With a total of two patents to his name, he has focused on improving methods for measuring hematocrit in blood, a vital parameter in medical diagnostics and monitoring.
Latest Patents
Billings' latest patents showcase his cutting-edge work in hematocrit measurement. One significant patent is titled "System and method for in-vivo hematocrit measurement using impedance and pressure plethysmography." This invention revolves around determining the hematocrit of blood perfusing a finger by stimulating it with two distinct current frequencies—high (e.g., 10 MHz) and low (e.g., 100 KHz). By capturing and separating the voltages induced in the finger, the hematocrit is calculated based on the relationship between the pulsatile and baseline components of these frequencies. Furthermore, the innovation incorporates the application of external pressure to enhance the blood volume during measurement, optimizing the accuracy of the results.
Career Highlights
Robert Billings is currently associated with Microcor, Inc., where he demonstrates his commitment to advancing medical technology through innovative solutions. His work focuses on non-invasive techniques that have the potential to transform patient care and monitoring in clinical settings.
Collaborations
Billings collaborates closely with colleagues Justin S. Clark and Jon Neese, contributing to the development of practical applications based on their collective expertise. Together, they aim to push the boundaries of existing technologies in healthcare and improve diagnostic methodologies.
Conclusion
Robert Gail Billings continues to make significant strides in the field of medical technology with his inventive approach to hematocrit measurement. His patents not only reflect his technical skills but also his commitment to improving healthcare outcomes through innovation. As he moves forward, the impact of his work will be closely monitored by both peers and industry leaders.